Asset Manager

Updated:

Palindrome

Palindrome is a private investment firm committed to the preservation of founder legacy, long-term ownership and culture. It focuses on companies with talented...

Palindrome logo

Palindrome

Palindrome is a private investment firm committed to the preservation of founder legacy, long-term ownership and culture. It focuses on companies with talented teams and decades of success and specializes in the industrial, manufacturing, agriculture and business services sectors. The firm uses a long-term buy-and-hold approach and invests in founder-led and family-owned businesses.

General information

Firm type

Generalist

Year founded

2018

Location

Region

North America

Country

United States

City

Spokane

Corporate office

3131 N Division St, Suite 105, Spokane, WA 99207, United States

Principals

Adam Gelhausen

Managing Partner

April Needham

Director, Portfolio Operations

Marna Stoove

Controller

Debra Straume

Operations Associate

Sector focus

Industrial TechAgriTech & FoodTechAerospaceBusiness Services

Frequently asked questions

Who runs investment decisions at Palindrome?

Palindrome does not publicly identify a named Chief Investment Officer, managing partner, or investment committee. The website lists Adam Gelhausen, April Needham, Marna Stoove, and Debra Straume without titles, alongside an advisory group that includes Greg Seibly, Ezra Eckhardt, and Sandy Young. The decision-making structure is not disclosed.

How does Palindrome structure its hold period for acquisitions?

Palindrome publicly states it buys companies and holds them indefinitely, distinguishing the firm from fund-cycle private equity. There is no disclosed fund vehicle or fixed exit horizon. This posture is designed to preserve founder legacy and maintain operational continuity over decades.

Which sectors does Palindrome explicitly avoid?

Palindrome does not publish an exclusion list. Its stated focus is industrial manufacturing, agriculture, aerospace, and business services. Software, consumer-facing, life sciences, and financial services are absent from its stated criteria and portfolio descriptions.

How is Palindrome's investment team compensated, and is there a disclosed carry structure?

Palindrome has not disclosed its compensation, carry, or fee structure. The firm does not publicly identify a fund structure, limited partners, or management-company economics, making it impossible to confirm standard carried-interest mechanics.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on asset managers?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Spokane Generalist profiles